Study Summary
This trial looks at how different colors on cigarette packaging affects how much people smoke and their perceptions of risk.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
5 Primary · 6 Secondary · Reporting Duration: Days 0, 5, 10, 20 and 35
Day 0
Cigarette Withdrawal (Withdrawal Symptom Checklist [WSC])
Day 35
Daily Cigarette Consumption
Puff Duration
Total Puff Count
Total Puff Volume/Puff Duration
Day 0
Carbon Monoxide (CO)
Cigarette Craving (Questionnaire on Smoking Urges [QSU])
Subjective Cigarette Ratings (Visual Analog Scale [VAS] of Cigarette Characteristics)
Day 0
Cigarette Risk Beliefs
Days 5 and 35
Total NNAL
Total Nicotine Equivalents
Trial Safety
Safety Progress
Trial Design
5 Treatment Groups
LNC Cigarettes + Red Packaging
1 of 5
Own Brand
1 of 5
LNC Cigarettes + Blue Packaging
1 of 5
LNC Cigarettes + Gray Packaging
1 of 5
LNC Cigarettes + Plain Packaging
1 of 5
Experimental Treatment
575 Total Participants · 5 Treatment Groups
Primary Treatment: LNC Cigarettes + Colored Packaging · No Placebo Group · N/A
LNC Cigarettes + Red Packaging
Other
Experimental Group · 1 Intervention: LNC Cigarettes + Colored Packaging · Intervention Types: OtherOwn Brand
Other
Experimental Group · 1 Intervention: Own Brand · Intervention Types: OtherLNC Cigarettes + Blue Packaging
Other
Experimental Group · 1 Intervention: LNC Cigarettes + Colored Packaging · Intervention Types: OtherLNC Cigarettes + Gray Packaging
Other
Experimental Group · 1 Intervention: LNC Cigarettes + Colored Packaging · Intervention Types: OtherLNC Cigarettes + Plain Packaging
Other
Experimental Group · 1 Intervention: LNC Cigarettes + Colored Packaging · Intervention Types: OtherTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: days 0, 5, 10, 20 and 35
Who is running the clinical trial?
Andrew StrasserLead Sponsor
2 Previous Clinical Trials
286 Total Patients Enrolled
Food and Drug Administration (FDA)FED
152 Previous Clinical Trials
953,236 Total Patients Enrolled
University of PennsylvaniaOTHER
1,841 Previous Clinical Trials
41,125,841 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,085 Previous Clinical Trials
41,140,936 Total Patients Enrolled
Andrew Strasser, Ph.D.5.08 ReviewsPrincipal Investigator - University of Pennsylvania
Englewood Hospital and Medical Center, Holy Name Hospital
Medical School - Rutgers, The State University of New Jersey, Doctor of Medicine
Thomas Jefferson University Hospital, Residency in Internal Medicine
4 Previous Clinical Trials
672 Total Patients Enrolled
5Patient Review
He was very thorough.
Eligibility Criteria
Age 21 - 65 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are not currently undergoing smoking cessation treatment or planning to quit over the duration of the study (~5 weeks).
You must be willing to stay in the study area for the duration of the study.
You are able to communicate in English.\n
You are capable of giving written informed consent.
Who else is applying?
What state do they live in?
| Pennsylvania | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Center for Interdisciplinary Research for Nicotine Addiction | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Why did patients apply to this trial?
- "This is my first time doing a clinical studies"
How many prior treatments have patients received?
| 0 | 100.0% |
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments